Bio-Techne TECH EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Bio-Techne’s reported figures.
Plus components not separately reported this period.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's EBIT?
- Bio-Techne (TECH) reported EBIT of $75.5M in Q1 2026.
- How has Bio-Techne's EBIT changed year-over-year?
- Bio-Techne's EBIT increased by 95.0% year-over-year, from $38.71M to $75.5M.
- What is the long-term trend for Bio-Techne's EBIT?
- Over 2 years (2022 to 2024), Bio-Techne's EBIT has grown at a -16.5% compound annual growth rate (CAGR), from $296.59M to $206.69M.
- What does EBIT mean?
- Profit before interest and taxes — the business's core earning power.
- How do you interpret EBIT?
- Higher is better. Because it adds back interest, EBIT compares earning power across firms with very different debt loads — the base for interest coverage and the EV/EBIT multiple. For filers reporting operating income it equals that line, excluding non-operating swings.
- How does EBIT compare across companies?
- Comparable across companies regardless of leverage or tax domicile; the standard 'earning power' line for cross-company analysis. Least meaningful for banks and insurers.